Apcegen Technologies

  • Bangalore, India
  • HealthcareBiotechnology, Healthcare

We are fully integrated Innovation driven biopharmaceutical company & aims to develop, manufacture and commercialize affordable biologics

Founded:
2010
Stage:
Proof of Concept
Market:
B2B

Startup Video

Featured

Image

Apcegen is ready to start non-clinical studies of its first alternate therapy biologic targeted agai | indiaprwire

Image

Apcegen Technologies secures NSTEDB and TePP funding's from DST | India PR Wire


Cell Line Development

Biosimilar Enbrel (Etanercept) Biosimilar EPO

Feb

2014

Early Stage PD and Product Characterization

Biosimilar Enbrel (Etanercept) Biosimilar EPO

Jun

Process Development and Engineering Runs

Alternate Therapy for RA - PEGhFab

Oct

Ready to Outlicense

Biosimilar Enbrel (Etanercept) Biosimilar EPO

Dec

Animal Studies

Alternate Therapy (RA) - PEGhFab

May

2015

Jobs


Team Summary


Team


    • Aashish Joshi

    • Scientist

    • Dr. Ashok Kumar

    • Mentor

    • Dr. Rajiv Mahajan

    • CTO

Product/Service Summary

Biotechnology based healthcare solutions. Current product Pipeline includes:
Biosimilar - Enbrel
Biosimilar - EPO
Alternate Therapy (Rheumatoid Arthritis and other related Auto-immune disorders) - PEGhFab
Biosimilar - clone for the treatment of Wet AMD

How are we different?

Proprietary expression platforms for Microbial and Mammalian systems,
Novel, scalable processes in microbial and mammalian systems.
Backed by Scientists form India's Premier Institutions..
Promoted by Industry experienced team.

Product/Service Descriptions